The Active Care Group were nominated in three categories at the prestigious HealthInvestor Awards, whilst Montreux Capital Management (UK) was shortlisted for Private Equity Investor of the Year.

The awards recognise ‘best in sector’ performance across a wide range of categories. The Active Care Group and its sub brands were nominated for:

  • Complex Care provider of the year – The Active Care Group
  • Recruiter of the Year – Jane Lewis
  • Community Support provider of the year – Neural Pathways

Montreux Capital Management (UK) was also nominated alongside other leading firms in the industry for Private Equity Investor of the Year, reflecting the role the business has played in a number of successful transactions over the past 12 months.

Oliver Harris, CEO, Montreux Capital Management (UK) stated: “We are honoured to be nominated across these categories which demonstrate the quality of the business. These nominations reflect the hard work of both The Active Group and MCM (UK) teams.”

The awards take place on the 12th June 2019.

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

ACCEPT